|
General Information
|
|
|
Product
|
Cytochrome P450 CYP307a1 Antibody Affinity Purified
|
|
Description
|
Affinity Purified Cytochrome P450 CYP307a1 Antibody
|
|
Verified Applications
|
ELISA, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Drosophila melanogaster
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 500-600 on D. melanogaster Spook protein.
|
|
Accession #
|
GenBank: AAQ05973.1
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.58-0.61 µg/µl in antibody stabilization buffer
|
|
Form
|
Affinity Purified
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
DB
|
1:10,000
|
|
ELISA
|
1:10,000
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
Q9VRM7
|
|
Overview
|
Required for correct development of the embryonic midline glial cells which are necessary for the formation of distinct segmental commissures.
|
|
Molecular Function
|
heme binding, iron ion binding, monooxygenase activity, oxidoreductase activity
|
|
Subcellular Location
|
endoplasmic reticulum membrane, peripheral membrane protein
|
|
Alternative Nomenclature
|
Cytochrome P450 307a1 antibody
307a1 antibody
CG10594 antibody
CYP307A1-Dm antibody
CG10594 antibody
Dmspo antibody
Spo antibody
spo spook antibody
|
| |
|
Cytochrome P450 CYP307a1 Antibody FITC
Cytochrome P450 CYP307a1 Antibody BIOTIN
Cytochrome P450 CYP307a1 Blocking Peptide
Cytochrome P450 CYP307a1 Positive Control
